Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Carcinoma, Lobular × Letrozole × Clear all

Phase

Status

Sponsor Class

INDUSTRY 3 OTHER 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Endometrial Neoplasms 2 Carcinoma, Ductal, Breast 2 Peritoneal Neoplasms 1 Fallopian Tube Neoplasms 1 Cystadenocarcinoma, Serous 1 Carcinoma, Lobular 1 Breast Neoplasms, Male 1 Breast Carcinoma In Situ 1 Breast Cancer Invasive Nos 1

Interventions

Tamoxifen 1 Pharmacogenomic Testing 1 Magnetic Resonance Spectroscopy 1 Letrozole 1 Docetaxel 1 Capecitabine 1 Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00433589 2022-11-17

MINDACT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡